It was another busy week for Australia's top brokers. This has led to the release of a number of broker notes.
Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone:
Image source: Getty Images
CSL Ltd (ASX: CSL)
According to a note out of Citi, its analysts have retained their buy rating and $345.00 price target on this biotechnology giant's shares. This follows the release of the quarterly update from rival Takeda Pharmaceutical Co Ltd (NYSE: TAK). Citi notes that Takeda's quarterly update revealed a strong increase in immunoglobulin products revenue over the prior corresponding period. It points out that this performance was in line with its expectations and believes it bodes well for CSL's performance during the first half of FY 2025. In fact, Citi highlights that Takeda's quarter supports its view that CSL will outperform the market's expectations for immunoglobulin and albumin sales during the half. In light of this, it continues to see plenty of value in its shares at current levels. The CSL share price ended the week at $285.29.
Mineral Resources Ltd (ASX: MIN)
A note out of Bell Potter reveals that its analysts have retained their buy rating and $61.50 price target on this mining and mining services company's shares. Bell Potter notes that Mineral Resources' founder and CEO, Chris Ellison, is stepping down after an internal investigation. It isn't overly concerned by the news and advised that it continues to base its investment view on the fundamentals of its business rather than focus on the CEO scandal. In addition, it thinks that once the dust settles and proposed actions are taken, Mineral Resources will continue to be an attractive investment. Though, it concedes that its share price could be volatile in the near term while its investigation continues and speculation mounts about what Ellison will do with his sizeable stake. The Mineral Resources share price was fetching $38.47 at the end of the week.
Xero Ltd (ASX: XRO)
Analysts at Macquarie have retained their outperform rating on this cloud accounting platform provider's shares with an increased price target of $188.50. According to the note, the broker believes that Xero is delivering with its profitable growth strategy. And while it acknowledges that the company is currently offering sign up discounts to new subscribers, it highlights that this makes little difference to long-term customer lifetime value. Outside this, the broker points out that artificial intelligence could support margin expansion in the coming years and sees potential for earnings boosts from ongoing product enhancements and strategic acquisitions. This includes the recent acquisition of cloud-based reporting, insights, and analytics platform, Syft. The Xero share price was trading at $157.00 on Friday.
